Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dale Taylor is active.

Publication


Featured researches published by Dale Taylor.


Biochemical Journal | 2002

Fate of haem iron in the malaria parasite Plasmodium falciparum

Timothy J. Egan; Jill M. Combrinck; Joanne Egan; G. R. Hearne; Helder M. Marques; Skhumbuzo Ntenteni; B. Trevor Sewell; Peter J. Smith; Dale Taylor; Donelly A. van Schalkwyk; Jason C. Walden

Chemical analysis has shown that Plasmodium falciparum trophozoites contain 61+/-2% of the iron within parasitized erythrocytes, of which 92+/-6% is located within the food vacuole. Of this, 88+/-9% is in the form of haemozoin. (57)Fe-Mössbauer spectroscopy shows that haemozoin is the only detectable iron species in trophozoites. Electron spectroscopic imaging confirms this conclusion.


ACS Chemical Biology | 2013

Insights into the Role of Heme in the Mechanism of Action of Antimalarials

Jill M. Combrinck; Tebogo E. Mabotha; Kanyile K. Ncokazi; Melvin A. Ambele; Dale Taylor; Peter J. Smith; Heinrich C. Hoppe; Timothy J. Egan

By using cell fractionation and measurement of Fe(III)heme-pyridine, the antimalarial chloroquine (CQ) has been shown to cause a dose-dependent decrease in hemozoin and concomitant increase in toxic free heme in cultured Plasmodium falciparum that is directly correlated with parasite survival. Transmission electron microscopy techniques have further shown that heme is redistributed from the parasite digestive vacuole to the cytoplasm and that CQ disrupts hemozoin crystal growth, resulting in mosaic boundaries in the crystals formed in the parasite. Extension of the cell fractionation study to other drugs has shown that artesunate, amodiaquine, lumefantrine, mefloquine, and quinine, all clinically important antimalarials, also inhibit hemozoin formation in the parasite cell, while the antifolate pyrimethamine and its combination with sulfadoxine do not. This study finally provides direct evidence in support of the hemozoin inhibition hypothesis for the mechanism of action of CQ and shows that other quinoline and related antimalarials inhibit cellular hemozoin formation.


African Journal of Research in Mathematics, Science and Technology Education | 2009

Mathematics and science teacher education in South Africa: A review of research, policy and practice in times of change

Jill Adler; Craig Pournara; Dale Taylor; Barbara Thorne; Grace Moletsane

Abstract The social, political and educational policy changes in South Africa provide a backdrop to this paper. Its authors report recent (2000–2006) research into the education of science and mathematics teachers in this country. International research trends provide a frame for the survey. Findings suggest that most of the research in both science and mathematics teacher education consists of small scale qualitative studies, generally conducted in urban contexts and among teachers participating in formal in-service programmes. In science teacher education, research emphases appear to have shifted towards process skill development, nature of science (NOS) and indigenous knowledge systems (IKS) while still acknowledging the importance of content knowledge. In mathematics teacher education research, there is a strong emphasis on the specificity of mathematical knowledge for mathematics teaching and teacher learning, with curriculum reform recently in focus in both mathematics and science teacher education literature. Gaps in the research have also been identified, including the education of primary mathematics and science teachers, teacher education for life sciences and the education of teachers in and for rural contexts. The authors argue for further research into mathematics and science teacher education and conclude with a research agenda focused on an examination of teacher education practices, investigations into primary teacher education, studies into life sciences teacher education and empirical research across diverse schooling contexts, with particular attention being paid to rural education.


Bioorganic & Medicinal Chemistry | 2012

Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy

Makoah N. Aminake; Aman Mahajan; Vipan Kumar; Renate H. Hans; Lubbe Wiesner; Dale Taylor; Carmen de Kock; Anne Grobler; Peter J. Smith; Marc W. Kirschner; Axel Rethwilm; Gabriele Pradel; Kelly Chibale

Malaria and HIV are among the most important global health problems of our time and together are responsible for approximately 3 million deaths annually. These two diseases overlap in many regions of the world including sub-Saharan Africa, Southeast Asia and South America, leading to a higher risk of co-infection. In this study, we generated and characterized hybrid molecules to target Plasmodium falciparum and HIV simultaneously for a potential HIV/malaria combination therapy. Hybrid molecules were synthesized by the covalent fusion of azidothymidine (AZT) with dihydroartemisinin (DHA), a tetraoxane or a 4-aminoquinoline derivative; and the small library was tested for antiviral and antimalarial activity. Our data suggests that compound 7 is the most potent molecule in vitro, with antiplasmodial activity comparable to that of DHA (IC(50)=26 nM, SI>3000), a moderate activity against HIV (IC(50)=2.9 μM; SI>35) and not toxic to HeLa cells at concentrations used in the assay (CC(50)>100 μM). Pharmacokinetics studies further revealed that compound 7 is metabolically unstable and is cleaved via O-dealkylation. These studies account for the lack of in vivo efficacy of compound 7 against the CQ-sensitive Plasmodium berghei N strain in mice, when administered orally at 20mg/kg.


Journal of Medicinal Chemistry | 2015

Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration

Renier van der Westhuyzen; Susan Winks; Colin R. Wilson; Grant Boyle; Richard K. Gessner; Candice Soares de Melo; Dale Taylor; Carmen de Kock; Mathew Njoroge; Christel Brunschwig; Nina Lawrence; Srinivasa Rao; Frederick A. Sirgel; Paul D. van Helden; Ronnett Seldon; Atica Moosa; Digby F. Warner; Luca Arista; Ujjini H. Manjunatha; Paul W. Smith; Leslie J. Street; Kelly Chibale

High-throughput screening of a library of small polar molecules against Mycobacterium tuberculosis led to the identification of a phthalimide-containing ester hit compound (1), which was optimized for metabolic stability by replacing the ester moiety with a methyl oxadiazole bioisostere. A route utilizing polymer-supported reagents was designed and executed to explore structure-activity relationships with respect to the N-benzyl substituent, leading to compounds with nanomolar activity. The frontrunner compound (5h) from these studies was well tolerated in mice. A M. tuberculosis cytochrome bd oxidase deletion mutant (ΔcydKO) was hyper-susceptible to compounds from this series, and a strain carrying a single point mutation in qcrB, the gene encoding a subunit of the menaquinol cytochrome c oxidoreductase, was resistant to compounds in this series. In combination, these observations indicate that this novel class of antimycobacterial compounds inhibits the cytochrome bc1 complex, a validated drug target in M. tuberculosis.


international symposium on biomedical imaging | 2011

Improved red blood cell counting in thin blood smears

Heidi Berge; Dale Taylor; Sriram Krishnan; Tania S. Douglas

Quantification of the extent of malaria parasite infection (parasitaemia) continues to rely on time-consuming manual microscopy of Giemsa-stained blood smears. We present an algorithm that counts red blood cells in thin blood smear images, the first step in the determination of malaria parasitaemia. Morphological methods and iterative thresholding are used for red blood cell segmentation, and boundary curvature calculations and Delaunay triangulation for red blood cell clump splitting. Our results compare well with those of published semi-automated methods, with an absolute error of 2.8% between manual and automatic counting of red blood cells.


Journal of Medicinal Chemistry | 2014

Medicinal Chemistry Optimization of Antiplasmodial Imidazopyridazine Hits from High Throughput Screening of a SoftFocus Kinase Library: Part 1

Claire Le Manach; Diego Gonzàlez Cabrera; Frederic Douelle; Aloysius T. Nchinda; Yassir Younis; Dale Taylor; Lubbe Wiesner; Karen L. White; Eileen Ryan; Corinne March; Sandra Duffy; Vicky M. Avery; David Waterson; Michael J. Witty; Sergio Wittlin; Susan A. Charman; Leslie J. Street; Kelly Chibale

A novel class of imidazopyridazines identified from whole cell screening of a SoftFocus kinase library was synthesized and evaluated for antiplasmodial activity against K1 (multidrug resistant strain) and NF54 (sensitive strain). Structure-activity relationship studies led to the identification of highly potent compounds against both strains. Compound 35 was highly active (IC50: K1 = 6.3 nM, NF54 = 7.3 nM) and comparable in potency to artesunate, and 35 exhibited 98% activity in the in vivo P. berghei mouse model (4-day test by Peters) at 4 × 50 mg/kg po. Compound 35 was also assessed against P. falciparum in the in vivo SCID mouse model where the efficacy was found to be more consistent with the in vitro activity. Furthermore, 35 displayed high (78%) rat oral bioavailability with good oral exposure and plasma half-life. Mice exposure at the same dose was 10-fold lower than in rat, suggesting lower oral absorption and/or higher metabolic clearance in mice.


Journal of Medicinal Chemistry | 2014

2,4-Diaminothienopyrimidines as orally active antimalarial agents.

Diego Gonzàlez Cabrera; Claire Le Manach; Frederic Douelle; Yassir Younis; Tzu-Shean Feng; Tanya Paquet; Aloysius T. Nchinda; Leslie J. Street; Dale Taylor; Carmen de Kock; Lubbe Wiesner; Sandra Duffy; Karen L. White; Mohammed K Zabiulla; Yuvaraj Sambandan; Sridevi Bashyam; David Waterson; Michael J. Witty; Susan A. Charman; Vicky M. Avery; Sergio Wittlin; Kelly Chibale

A novel series of 2,4-diaminothienopyrimidines with potential as antimalarials was identified from whole-cell high-throughput screening of a SoftFocus ion channel library. Synthesis and structure-activity relationship studies identified compounds with potent antiplasmodial activity and low in vitro cytotoxicity. Several of these analogues exhibited in vivo activity in the Plasmodium berghei mouse model when administered orally. However, inhibition of the hERG potassium channel was identified as a liability for this series.


European Journal of Medicinal Chemistry | 2013

Synthesis, characterization, antiparasitic and cytotoxic evaluation of thioureas conjugated to polyamine scaffolds

Tameryn Stringer; Dale Taylor; Carmen de Kock; Hajira Guzgay; Aaron Au; Seung Hwan An; Benjamin Sanchez; Raquel O'Connor; Neal Patel; Kirkwood M. Land; Peter J. Smith; Denver T. Hendricks; Timothy J. Egan; Gregory S. Smith

A series of mono- and multimeric 4-amino-7-chloroquinoline and ferrocenyl thioureas have been prepared by the reaction of a 7-chloroquinoline methyl ester and a ferrocenylimine methyl ester with various amines. These compounds were characterized using standard spectroscopic and analytical techniques. The compounds were evaluated against the NF54 (CQ-sensitive) and Dd2 (CQ-resistant) strains of Plasmodium falciparum. The quinoline compounds show enhanced activity compared to the ferrocene compounds against this parasite. Compound 5 displays the most promising activity against the NF54 strain. Compounds 5 and 6 are effective at inhibiting β-hematin formation perhaps due to an increased number of quinoline moieties. The trimeric (12) and tetrameric (13) ferrocenyl compounds also inhibit β-hematin formation, albeit to a lesser degree compared to the quinoline thioureas. The compounds were also screened against the G3 strain of Trichomonas vaginalis and here the ferrocene-containing compounds show a slightly higher parasite growth inhibition compared to the quinoline thioureas. The quinoline compounds were also found to be more cytotoxic compared to the ferrocenyl compounds. Compound 6 displays good cytotoxicity against WHCO1 oesophageal cancer cells.


European Journal of Medicinal Chemistry | 2013

In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles.

Mukesh C. Joshi; Kathryn J. Wicht; Dale Taylor; Roger Hunter; Peter J. Smith; Timothy J. Egan

A novel series of quinoline triazole amide analogues (38-51) has been synthesized. Analogues 38-44 had a Cl substituent at the 7-position of the quinoline ring, while 45-51 had a CN substituent at this position. Compounds 40, 45 and 49 were found to be the most active in the series against the Plasmodium falciparum chloroquine-sensitive D10 strain, with IC₅₀ values in the range of 349-1247 nM, with 40 and 45, but not 49 also exhibiting similar activity against the chloroquine-resistant K1 strain of parasite. Quinoline triazoles 40 and 44 were the most active β-haematin inhibitors, with 50% inhibitory concentrations of 14.7 and 8.9 μM respectively. In vitro antimalarial activity of the 7-Cl bearing analogues 38-44 exhibited a strong linear dependence of log(1/IC₅₀) on log P. Thus, the more lipophilic, the more active it was found be. The 7-CN series 45-51 showed no such dependence. The resistance index (IC₅₀ K1/IC₅₀ D10) also exhibited a linear dependence on log P, with a substantially steeper slope in the case of the 7-Cl series. The findings demonstrate the feasibility of producing hydrophilic analogues with strong activity and low cross-resistance with chloroquine.

Collaboration


Dive into the Dale Taylor's collaboration.

Top Co-Authors

Avatar

Kelly Chibale

South African Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sergio Wittlin

Swiss Tropical and Public Health Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tanya Paquet

University of Cape Town

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge